Boston Scientific Corporation Stock

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:02 2024-04-24 pm EDT 5-day change 1st Jan Change
72.91 USD +5.68% Intraday chart for Boston Scientific Corporation +7.28% +26.12%
Sales 2024 * 15.85B Sales 2025 * 17.36B Capitalization 107B
Net income 2024 * 2.11B Net income 2025 * 2.64B EV / Sales 2024 * 7.19 x
Net Debt 2024 * 6.82B Net Debt 2025 * 3.07B EV / Sales 2025 * 6.35 x
P/E ratio 2024 *
51.1 x
P/E ratio 2025 *
41.5 x
Employees 48,000
Yield 2024 *
-
Yield 2025 *
-
Free-Float 84.64%
More Fundamentals * Assessed data
Dynamic Chart
1 day+5.68%
1 week+7.28%
Current month+6.45%
1 month+7.82%
3 months+21.68%
6 months+43.07%
Current year+26.12%
More quotes
1 week
66.80
Extreme 66.8
74.39
1 month
66.80
Extreme 66.8
74.39
Current year
57.11
Extreme 57.11
74.39
1 year
48.35
Extreme 48.35
74.39
3 years
34.98
Extreme 34.98
74.39
5 years
24.10
Extreme 24.1
74.39
10 years
11.10
Extreme 11.1
74.39
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 11-10-16
Director of Finance/CFO 58 96-11-30
Chief Tech/Sci/R&D Officer - 09-08-31
Members of the board TitleAgeSince
Director/Board Member 61 21-06-22
Director/Board Member 69 15-03-31
Director/Board Member 72 14-02-28
More insiders
Date Price Change Volume
24-04-24 72.91 +5.68% 15,276,470
24-04-23 68.99 +1.43% 9,075,682
24-04-22 68.02 +1.02% 7,659,790
24-04-19 67.33 -0.13% 6,966,282
24-04-18 67.42 -0.79% 5,946,798

Delayed Quote Nyse, April 24, 2024 at 04:00 pm EDT

More quotes
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
72.91 USD
Average target price
77.37 USD
Spread / Average Target
+6.12%
Consensus